Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Nov 9.
Published in final edited form as: Methods Mol Biol. 2016;1400:261–280. doi: 10.1007/978-1-4939-3372-3_17

Immuno-Detection of Human LINE-1 expression

Reema Sharma 1, Nemanja Rodić 1, Kathleen H Burns 1, Martin S Taylor 1
PMCID: PMC5679191  NIHMSID: NIHMS850860  PMID: 26895059

Summary

Long INterspresed Element-1 (LINE-1) is the only active protein-coding retrotransposon in humans. It is not expressed in somatic tissue but is aberrantly expressed in a wide variety of human cancers. ORF1p protein is the most robust indicator of LINE-1 expression; the protein accumulates in large quantities in cellular cytoplasm. Recently, monoclonal antibodies have allowed more complete characterizations of ORF1p expression and indicated potential for developing ORF1p as a clinical biomarker. Here, we describe a mouse monoclonal antibody specific for human LINE-1 ORF1p and its application in immunofluorescence and immunohistochemistry of both cells and human tissues. We also describe detection of tagged LINE-1 ORF2p via immunofluorescence. These general methods may be readily adapted to use with many other proteins and antibodies.

Keywords: LINE-1 ORF1p, p40, immunofluorescence, immunohistochemistry, tissue microarray, tumor marker, biomarker

1. Introduction

Long INterspresed Element-1 (LINE-1) activity is a significant determinant of our genome sequence. LINE-1 and other sequences mobilized by LINE-1-encoded proteins together constitute about 35% of our DNA (1). Ongoing LINE-1 mediated retrotransposition makes these sequences important sources of genetic structural variation in humans as well as a source of instability in cancer genomes (2-6).

LINE-1 is the only active protein coding family of transposable elements in humans. The first of its two open reading frames encodes ORF1p, a 40 kD protein with RNA binding activities required for LINE-1 retrotransposition (7-9). The second, ORF2p, encodes the endonuclease and reverse transcriptase activities which are also essential for LINE-1 propagation (10, 11) and is expressed at extremely low levels (12).

ORF1p comprises an N-terminal domain, a coiled-coil domain (CCD), an RNA recognition motif (RRM), and a C-terminal domain. The protein associates with LINE-1 ribonucleoprotein (RNP) complexes as a trimer brought together through CCD interactions (13-15), and 2-10 trimers associate with each LINE-1 RNP (16). LINE-1 ORF1p is an abundant protein in cells expressing LINE-1. It can be readily seen on Coomassie gels of total protein when cells are transfected with LINE-1 expressing constructs under the native promoter; it may be a dominant band using CMV or CAG promoters. In terms of total protein expression, ratios of ORF1p:ORF2p are in the range of 1,000-10,000:1. Using immunoprecipitation and two distinct quantitative staining methods as well as quantitative mass spectrometry, the ratio of ORF1p:ORF2p in RNPs in these cells is between 6:1 and 30:1. Together, these data show that a substantial portion of ORF1p is not engaged in the LINE-1 RNP (16).

To develop a mouse monoclonal antibody to detect LINE-1, fifteen peptides from the human LINE-1 ORF1p sequence (AAB60344.1, 338 AA) were selected for immunization of BALB/c mice. The antibody referenced in this paper recognizes amino acids 35 to 44 (MENDFDELRE) of ORF1p (17). This is a region of the protein where mouse and human LINE-1 sequences diverge; it precedes the CCD and has not been solved in protein crystallography studies (15). Using immunohistochemistry, we found nearly half of human cancers stain positively for ORF1p, with immunoreactivity in some common cancers approaching 100% of cases. No staining was observed in the cognate normal tissues (17).

Materials

For cell culture IF

  1. Coverslips size 22×22×1: Fisher 12-542-B

  2. Slides size 25×75×1: Fisher 12-552-3

  3. Forceps: Electron Microscopy Services Style 4A, 78319-4A

  4. Parafilm M: 4″ width, Fisher S37440

  5. Hoesct 33342 trihydrochloride, trihydrate: 10 mg/mL Solution in Water: Life Technologies H3570

  6. Bovine serum albumin (BSA), High Avidity, 30% Solution: Sigma A3174

  7. PBS/Glycine: we make standard 10x PBS and a 100x glycine-azide stock. Sodium-only or sodium-potassium PBS recipes may be used.

  8. 100x Glycine: 1M glycine plus 2% sodium azide, adjust pH to 7.4. This is stable at room temperature for months to years.

  9. Mounting Media: 0.1M N-propyl-gallate in glycerol. Add N-propyl-gallate. Prepare and dissolve at 65°C overnight. Stable at room temperature for months to years.

  10. Fixative: 3% paraformaldehyde (PFA) in PBS (makes 100mL). Note: PFA is toxic. Weigh and dissolve in a fume hood and wear appropriate protection.
    1. Weigh 3g PFA, then add 80mL ddH2O and 250μL 1N NaOH.
    2. Heat at 50°C in a water bath to dissolve completely.
    3. Add 10mL 10x PBS and adjust volume to 100mL with ddH2O.
    4. Check pH, adjust to 7.4 with NaOH or HCl if needed.

For tissue IHC and IF

  1. Xylene

  2. Absolute ethanol

  3. TBS: 50mM Tris pH 7.4, 150mM NaCl

  4. TBST: TBS plus 0.05% Tween 20 (v/v)

  5. BSA

  6. BSA-TBST: 1% BSA (w/v) dissolved in in TBST

  7. Citrate antigen retrieval buffer: 10mM Sodium Citrate, pH 6.0, 0.05% Tween 20

  8. EDTA antigen retrieval buffer: 1mM EDTA, pH 8.0, 0.05% Tween 20

  9. 3 % Hydrogen Peroxide in dH2O (v/v)

  10. For signal amplification (option one): Histostain-SP Kit Broad Spectrum Kit: Life Technologies Cat#95-964

  11. For signal amplification (option two): EnVision™ HRP Mouse (DAB+) #K4006 or Rabbit (DAB+) #K4008

  12. For HRP-catalyzed amplified immunofluorescence using tyramide: Perkin Elmer™ TSA Plus Fluorescein (NEL741001KT) or Cy-5 (NEL745001KT)

Antibodies

Mouse anti-LINE-1 ORF1p clone 4H1 (10 mg/mL), stored in 50% glycerol at −20°C

Rabbit anti-LINE-1 ORF1p clone JH73 (gift of Jeff Han)

Alexa 488 GOAT Anti-Mouse: Invitrogen/Molecular Probes A-11029

Alexa 568 GOAT Anti-Rabbit: Invitrogen/Molecular Probes A-11036

Rabbit Anti-GFP polyclonal antibody: Invitrogen/Molecular Probes A-11122

Rabbit Anti-Flag polyclonal antibody: Sigma F7425

Mouse Anti-Flag M2: Sigma F1804 (Note: Mouse Anti-Flag M2 Sigma F3165 is not affinity purified but works equally well in our hands for this application.)

Methods

Immunofluorescence (IF) Detection of LINE-1 ORF1p and ORF2p from Human Cell Lines

Immunofluorescent staining (IF) for LINE-1 allows sensitive detection of LINE-1 expression and demonstrates subcellular co-localization of both ORF proteins. LINE-1 proteins accumulate in the cytoplasm and are relatively excluded from cell nuclei. For reasons that are not understood, we find that expression of tagged ORF2p in HEK-293T and HeLa cell lines varies greatly from cell to cell in a seemingly stochastic manner (16). IF was performed in transiently-transfected or puromycin-selected HeLa and HEK-293T cells grown on glass coverslips using both constitutive and tetracycline-inducible promoters, but this standard IF protocol works well with many cultured cell lines and antigens. Many IF protocols use hundreds of μL of antibody solution per sample and often take days to complete. With this protocol (18), slides can be visualized in less than 2 hours and, by using small droplets (50μL) of antibody on Parafilm M (Bemis), it saves limited and costly reagents. For ORF1p, untagged protein can be visualized using either of two recently-developed monoclonal antibodies, which were verified in comparison with Flag-tagged ORF1p. 3xFlag-tagged and GFP-tagged ORF2p can be detected readily; robust immunodetection of untagged ORF2p is currently a technical barrier in the field. Example images are shown in Figure 1.

Figure 1. Example immunofluorescent staining of LINE-1.

Figure 1

(A) Staining of HeLa cells expressing pLD401 (untagged ORF1, ORF2-3xFlag) using mouse anti-Flag and rabbit anti-ORF1 JH73. Top row: epifluorescence, 40x. Bottom row, confocal, 40x. (B) Staining of HeLa cells expressing pLD402 (untagged ORF1, ORF2-GFP) using rabbit anti-GFP and mouse anti-ORF1 4H1; epifluorescence, 64x. (C) Control staining of HeLa cells expressing pLD288 (ORF1-Flag, untagged ORF2) with rabbit anti-flag and mouse anti-ORF1 4H1; epifluorescence, 64x.

Many variations on the protocol below are effective. Here, we present our standard protocol for transient transfection, along with some options for customization.

Timeline

Day 1: Plating and Transfection

  • 9 am: Plating

  • 5 pm: Transfection

Day 2: Permeabilization, Fixation, and Immunostaining

Considerations

For optimal results, plating should occur >8 hours before transfection. For maximum transfection efficiency, cells can be plated 16-24 hours beforehand, but because this results in fewer single cells under the scope, we prefer using the 8 hour interval described. After 3 days on glass, cultured cells are often very clumpy and their borders may be difficult to distinguish. Therefore, for staining more than 18-24 hours after transfection, plating on coverslips can be done after transfection. ORF2p expression peaks at 20-24 hours post-transfection/induction and can be very difficult to detect at <16 hours.

Protocol

Day 1: Plating and Transfection

Plating considerations

For strongly-adherent cells such as HeLa, uncoated glass coverslips can be used. For weakly-adherent cells such as 293T or non-adherent hematopoietic lines, coverslips should be coated with a substrate to promote attachment of the cells. Fibronectin glycoprotein or poly-L-lysine, a positively charged synthetic amino acid chain, are widely used for this purpose. We autoclave coverslips in glass petri dishes; coverslips stuck together after autoclaving are discarded.

Coating coverslips with fibronectin
  1. Fibronectin from Human Plasma (Gibco 33016-015) is resuspended in sterile phosphate buffered saline (PBS) and stored in 60uL aliquots at −80°C.

  2. Dilute a 60uL aliquot 1:100 to 6mL in sterile PBS (10μg/mL final).

  3. With coverslips in 6-well wells or 35mm dishes, add 1mL to each coverslip, leaving it beaded up on top of the glass.

  4. Incubate >2hrs at room temperature in a tissue culture hood. Alternatively, >1hr at 37°C, or overnight at 4°C. For overnight incubation, seal with Parafilm.

  5. When ready to use, aspirate and wash with PBS or media.

Coating coverslips with poly-L-lysine

Poly-L-lysine is less expensive than fibronectin and works well with HEK-293T cells.

  1. Sigma P1524 (mol wt ≥300,000) is dissolved to 10mg/mL in sterile ddH2O and 400μL aliquots are stored at −20°C.

  2. Make 4mL of a 1mg/mL working dilution in ddH2O (400μL stock + 3.6mL ddH2O).

  3. With coverslips in 35mm dishes or 6-well plates, apply the solution to each coverslip for ~30 seconds to 1 min.

  4. Pipet to sequential dishes/wells, coating ~5-10 per 1mL solution. We routinely coat up to 40 coverslips with 4mL.

  5. Wash each coated coverslip with 2×1mL ddH2O, aspirating off all of the solution.

  6. After the second wash, aspirate all the water off and allow to air dry completely in the hood. (Note: The drying process is important for surface stickiness.)

  7. Store at room temperature for weeks to months before use, or use once dry (minimum ~30min).

Plating

Cultured cells can be subconfluent or confluent, but not overgrown.

  1. Insert an autoclaved coverslip or coated coverslip into each 35mm dish or 6-well plate, discarding coverslips that are clumped together

  2. If plating HEK-293T the day before staining as in the above timeline, plate 300,000-400,000 cells. Plate 200,000 if plating the day before transfection (2 days on the plates). If cells are to be on the plates longer than two days, plate fewer cells.

Transfection

We prefer Fugene 6 or HD (Promega) over Lipofectamine (Life Technologies) and XtremeGene (Roche) reagents in HEK-293T and HeLa due to reduced toxicity and better reproducibility. Transfection is done following manufacturer’s standard protocol with a 3μL:1μg ratio of reagent:DNA. DNA should be midi- or maxi-prepped; minipreps are not suitable.

Day 2: Fixation, Permeabilization, and Staining

Note: It is critical not to let the coverslips dry out. They should be without buffer for the shortest time possible. When working with many samples, aspirate one 6-well plate at a time, wash that plate, and then move to the next samples.

Paraformaldehyde (PFA) Fixation and Triton Permeabilization

This is a standard fixation method for immobilizing antigens. Paraformaldehyde acts as a cross-linking reagent and is followed by permeabilization with Triton X-100 detergent (Sigma). After PFA fixation, glycine is added to the buffers as both a quench and blocking agent. Saponin detergent is also popular and may expose different epitopes. A methanol treatment at −20°C can be used as an alternative to crosslinking fixation and permeabilization. Organic solvent fixations remove lipids and dehydrate cells and may provide better access to antigens or better preservation of some organelles such as the endoplasmic reticulum.

  1. Thaw an aliquot of 3% PFA solution.

  2. Make fresh working stock of 0.5% Triton X-100 in PBS/glycine from 10% stock (at least 1mL per sample).

  3. Aspirate media, wash cells with PBS (without glycine).

  4. Aspirate wash and fix cells: add 1mL 3% PFA in PBS for 10min.

  5. Aspirate PFA, wash with PBS/Glycine.

  6. Aspirate wash. Permeabilize cells by adding 1mL fresh 0.5% Triton X-100 in PBS/glycine. Incubate 3 min at room temperature.

  7. Rinse in PBS/Glycine, let sit in PBS/glycine for at least 5 min to fully quench (or longer).

Immunostaining

To minimize the volume of antibody solution used, we take advantage of the hydrophobicity of Parafilm M, applying the coverslip cell-side-down onto a beaded drop of antibody solution. The cell side of the coverslip is coated in the antibody solution via surface tension. The minimum volume required for this using a standard 22mm coverslip is approximately 35μL; the extra volume reduces edge drying and makes handling the coverslips easier. All antibodies are diluted in PBS/Glycine/1% bovine serum albumin (BSA); BSA serves as both diluent and blocking agent.

Multi-channel fluorescent staining and the species problem

Using standard UV-fluorescent microscopes and fluorophores, up to four orthogonal channels may be studied simultaneously; our common filter set is blue/DAPI (excite: 360 nm, emit: ~460 nm), green/FITC (excite: 488 nm, emit: ~525 nm), red/Texas Red (excite: 568 nm, emit: ~615 nm), and far-red/Cy5 (excite: 633 nm, emit: ~680 nm; Note: Far-red is not visible to the eye and requires charge-coupled device (CCD) camera-based detection). Thus, in principle, up to four different targets may be visualized simultaneously using immunofluorescence. In practice, the ultraviolet channel is usually reserved for DNA dyes (DAPI, Hoechst), and detecting three different targets requires primary antibodies produced in three different species with a panel of orthogonally-reactive fluorescent-labeled secondary antibodies. In selecting the panel of secondary antibodies, using three antibodies raised in the same species can reduce background. Further, using highly cross-adsorbed secondary antibodies can eliminate cross-binding to off-target primary antibodies. Note that in the first use of any secondary antibody combination, it is important to include “no-primary” controls for each primary antibody individually. We have had good success using Alexa-fluor labeled highly cross-adsorbed goat antibodies from Life Technologies, with combinations of anti-mouse-rabbit-chicken, anti-mouse-rabbit-rat, and anti-mouse-rabbit-sheep.

For LINE-1, a typical staining is a rabbit anti-ORF1p monoclonal JH73 (0.25μg/mL) and mouse anti-Flag M2 (2μg/mL, ORF2p-3xFlag) along with Hoechst stain for DNA, and might include chicken anti-actin. In our hands, the signal-to-noise ratio tends to be better in the green (488 nm) channel, so we usually stain for ORF2p with this secondary antibody. Alternatively, mouse anti-ORF1 4H1 (1μg/mL) can be used with rabbit polyclonal anti-flag (Sigma) or many other commercial DYKDDDK reagents, however the 3xFlag signal is weaker in this case because the 3xFlag tag is optimized for binding the M2 antibody.

  1. Dilute primary and secondary antibodies. Note: primary antibody dilutions should be optimized. First make a solution of PBS/Glycine/1% BSA using the 30% BSA stock. Helpful trick: If more than one combination of primary antibody is being used (or if any volume needed to pipet is less than 0.5μL), it is helpful to first make 2x working stocks of each antibody (or 3x stocks for 3-channel immunostaining).

  2. Stretch and label Parafilm on the bench as in Figure 2. Label each square with both the coverslip number and which stain that square receives.

  3. Add 50μL of the primary antibody mix to the center of the corresponding squares on the Parafilm. Avoid bubbling the drop.

  4. Using a pair of sharp forceps, carefully remove the coverslip from the dish. (This is much easier with buffer present.) Dry the cell side of the coverslip by blotting and flip it cell-side-down onto the antibody drop. (See Figure 3.) Incubate 20 minutes at room temperature.
    1. Set a stack of two paper towels on the bench for blotting.
    2. Lift the coverslip with fine forceps. Note: If using plastic dishes, pinch firmly to free the coverslip.
    3. Very coordinated scientists can use forceps to flip, blot, and transfer the coverslip to the drop. For the rest of us, to avoid coverslip breakage and ensuing frustration, we recommend the following method: (Right-handedness is presumed.)
      1. Lift the coverslip with forceps and transfer the coverslip into your left hand, holding it gently by the edges and paying careful attention to which side is the cell side. Set the forceps down and transfer the coverslip back to your right hand, grasping the free edges.
      2. Angle the coverslip downwards, cell-side down. A drop of liquid will accumulate in the corner. Gently blot the edge on the paper towel, then set the coverslip cell-side-down down on the antibody droplet.
      3. Notes:
        1. During this step it is easy to make a mistake and shatter the coverslip by dropping it or lose track of which side has the cells. Work carefully and focus, it gets easier with practice.
        2. If the coverslip falls and you aren’t sure which side the cells are on, the best way to check is to lift the slip and carefully scrape a corner. The cell side scrapes clean, nothing happens on the other side.
        3. If you break a coverslip, it may be salvaged by continuing with the largest piece. Just be careful not to cut your finger or damage a microscope objective on the broken glass edge.
  5. During the incubation, aspirate the PBS/Glycine out of the dishes and replace with fresh buffer for the first wash.

  6. Using forceps, carefully lift the coverslip off the Parafilm and flip it back CELL SIDE UP into the dish (containing fresh PBS/Glycine wash).
    1. You can keep the coverslip from sliding away by putting a fingernail on the opposite side.
    2. Note: It is helpful if the forceps have a very slight upward curve, to prevent stabbing into the Parafilm. If the tip of the instrument is getting stuck in the Parafilm, try using the other tip (flip them over), or gently bend the end inward.
  7. Shake gently to wash, aspirate off the wash.

  8. Wash again with PBS/Glycine.

  9. Clean the Parafilm with a paper towel and rinse, dry, and repeat for 2 washes total. (Alternatively, replace the Parafilm with a clean sheet.)

  10. Stain with secondary antibody: Repeat steps 2-7 using the secondary antibody, but modify the wash procedure as below to include Hoechst stain in the first wash.
    1. During the secondary antibody incubation, make a working stock of Hoechst DNA Dye by diluting the 10 mg/mL stock 1:100,000 total in PBS/Glycine in sequential 1:100 and then 1:1000 dilutions (final 100 ng/mL).
    2. Add 1mL to each well for the first wash. Once the coverslips are added, incubate 5 min at room temperature.
    3. Aspirate and wash with PBS/Glycine. Let sit in PBS/Glycine until ready to mount.
Figure 2. Antibody droplets on Parafilm M.

Figure 2

For each coverslip, one square of 4″ wide Parafilm M is used. Label each square with the antibody combination to be used. Pipet a 50μL droplet of primary or secondary antibody, and then apply the coverslip cell-side-down for 20 min at room temp. Note 30-35μL is the minimum needed, but higher volume increases consistency and ease of handling. Avoid bubbling the drop; remove bubbles with a pipet.

Figure 3. Transferring the coverslip from dish or plate to droplets on Parafilm.

Figure 3

Lift the coverslip from buffer-containing dish/plate with forceps (1). With dishes, pinching the dish firmly (red arrows) helps. Wear gloves. To avoid breaking or dropping the coverslip, transfer the coverslip carefully from the forceps to the left hand (2), then back to the right hand (3) as shown. Tilt the coverslip so that a drop forms in the corner (4) and blot the bulk off using a small stack of paper towels, touching only the edges of the slide to the paper towel. Set the blotted coverslip cell-side-down on the drop (5). If any bubble forms, gently chase it out by pushing on the back or lift the coverslip and remove. Incubate for 20 min at room temperature. To lift coverslip, use a finger and gentle pressure as shown to keep the coverslip in place (6).

Mounting

Many different mounting media are available, and there are pros and cons to each. We typically use a simple and inexpensive mounting media using 0.1M N-propyl gallate in glycerol (19). Slides are stable for weeks-to-months if stored flat, and can be viewed on the scope the instant they are mounted. They can also be un-mounted easily if needed. Commercial mounting media such as VECTASHIELD (Vector labs) and ProLong (Life Technologies) are popular and more permanent, but some require solvents and longer drying times, and all are more expensive. Some mounting media also contains DAPI stain. We prefer not to seal coverslips with clear nail polish as the raised surface can damage microscope objectives, although this can be helpful for preserving slides with liquid mounting media over time.

  1. Pre-label the slides, clean with Kimwipes and/or a compressed air can. Each slide should be marked with sample name, date, permeabilization, and stain, as appropriate. If two samples are to be compared directly, it is helpful to put both coverslips on the same slide.

  2. To mount each coverslip, we follow a protocol analogous to the staining procedure, followed by aspiration of excess mounting media.
    1. Put a drop of mounting media for each coverslip on the slide. Remove the coverslip from the dish, blot to remove buffer from the cell side, and then flip cell-side-down onto the drop. It may be helpful to dry the back of the coverslip before mounting.
    2. Apply gentle downward pressure on each coverslip with index and middle fingers and a cut pipet-tip aspirator while aspirating excess mounting media from around the edges of the coverslip. Then, maintain firm downward pressure with your fingers. Pushing downward and sideways with the plastic pipet tip against the top of the glass coverslip, chasing out large bubbles and continuing to remove excess mounting media accumulating at the edges of the glass. Push firmly enough to move air bubbled to the edge but not excessively, as sliding coverslips or excessive pressure can shear the cells.
    3. For those inclined to remove every single drop of excess mounting media, allow the slides to sit a few minutes and then make a second pass over the completed slides.

Immunohistochemical (IHC) and Immunofluorescent (IF) Detection of LINE-1 ORF1p from human tissues

This protocol describes immunolabeling of formalin fixed, paraffin-embedded (FFPE) tissue sections using the monoclonal antibody for LINE-1 ORF1p. This is a general staining protocol we have used in human pancreatic tissue, but it can be modified to accommodate staining of other tissues and cell lines. Two alternative approaches for detection are described here: immunohistochemistry (IHC), where protein of choice is detected via binding of a chromogen such as 3,3′-Diaminobenzidine (DAB) and visualized using a light microscope; or immunofluorescence (IF), where the protein of choice is detected via binding of fluorophores and visualized using a fluorescence microscope. Alternatives to DAB for immunohistochemistry include chromogens such as 3-amino-9-ethylcarbazole (AEC). Both the IHC and IF protocols described herein have been optimized and validated with proprietary signal amplification technologies as well as fluorescent-conjugated secondary antibodies. We routinely use 10% neutral buffered formalin for tissue fixation, although B5, Bouin’s, Zinc formalin or alcohol-based fixatives are also commonly used.

For IHC, in (17) we used Invitrogen’s Histostain-Streptavidin-Peroxidase (SP) Broad Spectrum Kit (Cat#95-9643) for LINE-1 ORF1p detection, with a protocol modified from that provided by the manufacturer. The kit uses a biotinylated secondary antibody and horseradish peroxidase-labelled streptavidin for signal amplification. This complex is then visualized through the use of a DAB chromogen mixture and results in highly specific signal for LINE1 ORF1p. Example IHC images of LINE-1 ORF1p using the 4H1 monoclonal antibody are shown in Figure 4.

Figure 4. IHC staining of LINE-1 ORF1p in Pancreatic Ductal Adenocarcinoma.

Figure 4

(A) and (C): Anti-ORF1p stained sections with hematoxylin counterstain. (B) and (D): Hematoxylin and Eosin (H&E) stain corresponding to (A) and (C), respectively.

As an alternative to the Histostain kit, we use the EnVision™ System for signal amplification (Dako North America, Inc., Carpinteria, CA). EnVision™ consists of a poly - Horseradish peroxidase (HRP) chain secondary antibody. In our experience, this system gives more robust signal over background than the Histostain kit.

For immunofluorescence, detection can be achieved directly with fluorescent-conjugated secondary antibodies; we prefer Alexa-fluor labeled antibodies raised in goat as described in cell culture immunofluorescence above. Alternatively, either of the Histostain or EnVision™ HRP-based amplification systems can be used with the Tyramide Signal Amplification™ (TSA™) System (PerkinElmer, Inc., Waltham, MA) for increased sensitivity. A variety of fluorescent substrates are available for TSA™; we mostly use TSA™-plus fluorescein and TSA™-plus Cyanine-5 (Cy-5). Multiplexed immunofluorescent detection using TSA and EnVision is described in (20).

A common protocol follows for deparaffinization through primary antibody incubation. The protocol splits at this point for IHC and IF.

Protocol

Deparaffinization and rehydration

  1. Label slides with a pencil. Note: Ink from many laboratory markers will wash off in ethanol.

  2. Bake slides at 60°C for 20-30 min to melt paraffin.

  3. Perform the following series of washes to remove paraffin:
    1. Xylene washes for 5 minutes, 5 minutes, and 3 minutes. (Using the fume hood.)
    2. Wash in 100% Ethanol for 2 minutes. Repeat twice for a total of three washes.
    3. Wash in 95% Ethanol for 2 minutes. Repeat twice for a total of three washes.
    4. Rinse under streaming tap water for 5 minutes.

Antigen Retrieval

Formalin and other aldehyde-based tissue fixations form extensive protein crosslinks which require a subsequent antigen retrieval step for antibody penetration and antigen unmasking.

Our standard retrieval protocol uses a steamer as follows:

  1. Immerse slides in citrate antigen retrieval buffer (pH 6).

  2. Transfer the buffer and slides to a steamer and heat at 98°C for 20 minutes.

  3. Remove slides from steamer and allow them to cool to room temperature.

  4. Place in TBST buffer.

An EDTA antigen retrieval buffer can be used in lieu of the citrate antigen retrieval solution. In addition, the alternate hot plate approach below can be applied using either the citrate or EDTA buffers. Thus, we provide four (4) different variations on conditions for antigen retrieval. Alternatively, several manufacturers make automated antigen retrieval systems using either heat or microwave energy; a review of these devices and their application is beyond the scope of this chapter. We suggest using the standard protocol above first and applying alternate protocols for optimization or based on the availability of heating equipment.

Alternate retrieval protocol: Hot plate approach

  1. Heat retrieval buffer to 55°C.

  2. Immerse the rehydrated slides and increase the temperature to 95°-98°C.

  3. Incubate for 30 minutes.

  4. Let the slides cool to at least 45°C in the antigen retrieval buffer. This step typically takes about 45 minutes.

  5. Rinse under streaming tap water for 5 minutes.

General Note

The volume of each reagent used per slide from here on varies according to the surface area of the tissue. Reagent volumes can range between 100μL to 1mL per slide. It is recommended to add certain reagents (including blocking reagent, primary and secondary antibody solutions, chromogen and fluorophore mixes, and counterstains) drop-wise to minimize their use.

Permeabilization and Blocking

Two things are accomplished in this blocking protocol. First, activities of endogenous peroxidases are quenched. The protocol below uses a 3% hydrogen peroxide solution; an alternative is to use Peroxo-Block™ (Invitrogen Cat. No. 00-2015). Secondly, blocking of non-specific interactions is achieved using a 10% non-immune serum blocking solution (Histostain kit) or BSA.

  1. Remove slides from TBST and wipe off any residual buffer on the slides using Kimwipes, gently drying the underside and edges. Take care to leave a small amount of buffer overlying the tissue, because drying the tissue during this step with interfere with antibody binding in subsequent steps.

  2. Incubate samples with 3% Hydrogen Peroxide for 5 min at room temperature.

  3. Rinse slides with TBST (with shaking) for 5 minutes.

  4. Block:
    1. Incubate samples with the blocking reagent (Reagent 1A, Histostain kit) at room temperature for 10 minutes.
    2. Alternatively, overlay slides with 500-1000 μL of BSA-TBST blocking solution and pre-incubate in a humid chamber for 30 minutes at room temperature.
      Note: We make the humid chamber using a small sealable plastic container, lined on the bottom with damp paper towels and containing an elevated stage to hold the slides.

Primary Antibody Incubation

  1. Remove slides from TBST and carefully wipe off any residual buffer on the slides.

  2. Dilute LINE-1 ORF1p antibody with BSA-TBST (TBST with 1% BSA) to 1 μg/mL. The use of BSA reduces non-specific binding of the primary antibody.

  3. Add enough diluted primary antibody to cover the tissue and incubate overnight at 4°C in a humid chamber.

  4. Remove primary antibody solution and wash with TBST for 5 minutes. Repeat twice for a total of three washes.

Up to this point, the protocol has been identical for IF and IHC. We describe several approaches for subsequent staining:

  • IF with fluorescent-conjugated secondary antibodies.

  • IHC or IF with signal amplification using Histostain or EnVision ∣ reagents, followed by chromogenic or TSA-based IF detection.

Three starting points for these protocols follow:

  • Fluorescent Secondary Antibody Incubation for IF

  • Secondary Antibody Incubation, Chromogen Incubation, and Counterstain: Histostain Kit

  • Secondary Antibody Incubation, Chromogen Incubation, and Counterstain: EnVision∣ Kit

Departure points from each of the latter two methods to Amplified Immunofluorescence Using TSA are noted. Finally, IHC detections conclude with Dehydration & Coverslipping (for IHC Only), and IF detections with Coverslipping (for IF Only) protocols.

Fluorescent Secondary Antibody Incubation for IF

  1. Remove slides from TBST and carefully wipe off any residual buffer on the slides.

  2. Dilute fluorescent conjugated secondary antibody or antibodies in BSA-TBST to 2 μg/mL (1:1000 for Alexa Fluor conjugated goat antibodies).

  3. Add enough diluted antibody to cover the tissue and incubate 1 hr at room temperature in a humid chamber.

  4. Remove the primary antibody solution and wash with TBST for 5 minutes. Repeat twice for a total of three washes.

  5. Proceed to Coverslipping (for IF Only).

Secondary Antibody Incubation, Chromogen Incubation, and Counterstain: Histostain Kit

  1. Incubate slides with a biotinylated secondary antibody: pipet Reagent 1B over tissue and incubate at room temperature for 10 minutes.

  2. Remove the secondary antibody solution and wash with TBS (no tween) for 2 minutes. Repeat twice for a total of three washes.

  3. Incubate slides with a streptavidin-peroxidase conjugate (Reagent 2) at room temperature for 10 minutes.

  4. Remove the enzyme conjugate solution and wash with TBS (no tween) for 2 minutes. Repeat twice for a total of three washes.

    If performing IF using the Histostain Kit, jump to the Amplified Immunofluorescence Using TSA (for IF Only) protocol below. Otherwise, for IHC, continue to Step 5 immediately below.

  5. Incubate samples with DAB Chromogen Mix (1 drop each of Reagents 3A, 3B, & 3C added to 1 mL water). The DAB Chromogen Mix should be protected from light and used immediately after mixing. The ideal development time for pancreatic tissue usually occurs at approximately 10 minutes but may vary across samples. Color development (brown) should be monitored using a light microscope.

  6. Rinse with deionized water for 3 minutes with shaking. Repeat once for a total of two washes.

  7. Incubate with the hematoxylin solution (Reagent 4). The ideal staining time for pancreatic tissue is approximately 7 minutes but may vary across samples.

  8. Rinse with deionized water for 3 minutes with gentle shaking.

  9. Proceed to Dehydration & Coverslipping (for IHC Only).

Secondary Antibody Incubation, Chromogen Incubation, and Counterstain: EnVision™ Kit

  1. Select the species-appropriate EnVision™ solution. Solutions are available with peroxidase-labeled polymers conjugated to anti-mouse or anti-rabbit antibodies.

  2. Pipette the EnVision™ solution and incubate in a light-protected humid chamber for 1 hour at room temperature. Note: The binding time is a step that can be optimized for each primary antibody.

  3. Wash a total of 3 times with TBST.

    If performing IF using the EnVision™Kit, jump to the Amplified Immunofluorescence Using TSA (for IF Only) protocol below. Otherwise, for IHC, continue to Step 4 immediately below.

  4. Prepare substrate-chromogen solution which consists of 1 drop (20 μL) of DAB+ Chromogen added to 1 mL DAB+ Substrate Buffer. Use this solution immediately after mixing.

  5. Wipe excess liquid off of the slides and pipette DAB Mixture onto each slide.

  6. Rinse with deionized H2O for 3 minutes with shaking. Repeat once for a total of two washes.

  7. Wipe excess liquid off of the slides and pipette on a small amount of hematoxylin, enough to cover the tissue surface, and incubate at room temperature for 1 minute.

  8. Rinse slides in deionized H2O for 3 minutes with gentle shaking.

  9. Proceed to Dehydration & Coverslipping (for IHC Only).

Dehydration & Coverslipping (for IHC Only)

  1. Sequentially dehydrate samples by immersing them in the following series of increasing ethanol concentrations and ending with xylene:
    1. Water, 5 minutes.
    2. 70% ethanol, 2 minutes.
    3. 95% Ethanol, 2 minutes. Repeat once for a total of two 95% EtOH soaks.
    4. 100% Ethanol, 2 minutes. Repeat twice for a total of three 100% EtOH soaks.
    5. Xylene for 3 minutes, 5 minutes, and 5 minutes (fume hood).
  2. Remove slides from xylene and wipe excess solution of the underside and sides of the slides; as before, make sure not to allow the tissue to dry entirely.

  3. Add a few drops of HistoMount™, CytoSeal™ 60, or other mounting medium and coverslip immediately.

    Note: Use gloves during this step, because any fingerprint(s) on the coverslip may interfere with subsequent microscopic analysis. Allow slides to dry in hazardous chemical hood, label with permanent marker, and store slides at room temperature.

Amplified Immunofluorescence Using TSA (for IF Only)

  1. Remove TBST, wipe slides carefully with Kimwipes, making sure not to dry out the tissue.

  2. Dilute fluorophore-tyramide 1:50 (Cy-5) or 1:100 (fluorescein) in Amplification Diluent and pipet enough reagent to cover tissue.

  3. Incubate in the dark at room temperature for 10 minutes.

  4. Rinse slides in 1X TBST for 5 minutes with shaking. Repeat once.

  5. Proceed to Coverslipping (for IF Only).

Coverslipping (for IF Only)

  1. Aliquot 50 to 100 μL of ProLong Gold with 4′,6-diamidino-2-phenylindole (DAPI) solution onto slides.

  2. Incubate in the dark at room temperature for 5 minutes.

    Notes: Keep slides protect from light from the beginning of this step and onwards.

    Other mounting media (as described in the cultured cell IF protocol above) can be used here as well.

  3. Place a coverslip cleaned with a Kimwipe or an air can duster carefully onto slides.

    Note: Use gloves during this step, because any fingerprint(s) on the coverslip may interfere with subsequent microscopy. Label slides with permanent marker. Store slides shielded from ambient light at room temperature or 4°C.

Acknowledgement

We thank Carolyn Machamer and Travis Ruch for their immunofluorescence expertise. We thank Jeff Han for the gift of rabbit anti-ORF1 JH73. We thank Norman Barker for photography of IHC slides. Funding for these projects has been provided in part by R01CA163705 (KHB) and the Burroughs Wellcome Fund Career Awards for Medical Scientists (KHB).

References

  • 1.Lander ES, et al. Initial sequencing and analysis of the human genome. Nature. 2001 Feb 15;409:860. doi: 10.1038/35057062. [DOI] [PubMed] [Google Scholar]
  • 2.Burns KH, Boeke JD. Human transposon tectonics. Cell. 2012 May 11;149:740. doi: 10.1016/j.cell.2012.04.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shukla R, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell. 2013 Mar 28;153:101. doi: 10.1016/j.cell.2013.02.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ostertag EM, Kazazian HH., Jr. Biology of mammalian L1 retrotransposons. Annu.Rev.Genet. 2001;35:501. doi: 10.1146/annurev.genet.35.102401.091032. [DOI] [PubMed] [Google Scholar]
  • 5.Hancks DC, Kazazian HH., Jr. Active human retrotransposons: variation and disease. Current opinion in genetics & development. 2012 Jun;22:191. doi: 10.1016/j.gde.2012.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 elements in structural variation and disease. Annual review of genomics and human genetics. 2011;12:187. doi: 10.1146/annurev-genom-082509-141802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Martin SL, Bushman FD. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Molecular and cellular biology. 2001 Jan;21:467. doi: 10.1128/MCB.21.2.467-475.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kolosha VO, Martin SL. High-affinity, non-sequence-specific RNA binding by the open reading frame 1 (ORF1) protein from long interspersed nuclear element 1 (LINE-1) J Biol Chem. 2003 Mar 7;278:8112. doi: 10.1074/jbc.M210487200. [DOI] [PubMed] [Google Scholar]
  • 9.Martin SL, et al. LINE-1 retrotransposition requires the nucleic acid chaperone activity of the ORF1 protein. Journal of molecular biology. 2005 May 6;348:549. doi: 10.1016/j.jmb.2005.03.003. [DOI] [PubMed] [Google Scholar]
  • 10.Feng Q, Moran JV, Kazazian HH, Jr., Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 1996 Nov 29;87:905. doi: 10.1016/s0092-8674(00)81997-2. [DOI] [PubMed] [Google Scholar]
  • 11.Mathias SL, Scott AF, Kazazian HH, Jr., Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science. 1991 Dec 20;254:1808. doi: 10.1126/science.1722352. [DOI] [PubMed] [Google Scholar]
  • 12.Alisch RS, Garcia-Perez JL, Muotri AR, Gage FH, Moran JV. Unconventional translation of mammalian LINE-1 retrotransposons. Genes & development. 2006 Jan 15;20:210. doi: 10.1101/gad.1380406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Martin SL, Branciforte D, Keller D, Bain DL. Trimeric structure for an essential protein in L1 retrotransposition. Proceedings of the National Academy of Sciences of the United States of America. 2003 Nov 25;100:13815. doi: 10.1073/pnas.2336221100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Callahan KE, Hickman AB, Jones CE, Ghirlando R, Furano AV. Polymerization and nucleic acid-binding properties of human L1 ORF1 protein. Nucleic acids research. 2012 Jan;40:813. doi: 10.1093/nar/gkr728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Khazina E, et al. Trimeric structure and flexibility of the L1ORF1 protein in human L1 retrotransposition. Nature structural & molecular biology. 2011 Sep;18:1006. doi: 10.1038/nsmb.2097. [DOI] [PubMed] [Google Scholar]
  • 16.Taylor MS, et al. Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition. Cell. 2013 Nov 21;155:1034. doi: 10.1016/j.cell.2013.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rodic N, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American journal of pathology. 2014 May;184:1280. doi: 10.1016/j.ajpath.2014.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hicks SW, Machamer CE. The NH2-terminal domain of Golgin-160 contains both Golgi and nuclear targeting information. J Biol Chem. 2002 Sep 27;277:35833. doi: 10.1074/jbc.M206280200. [DOI] [PubMed] [Google Scholar]
  • 19.Giloh H, Sedat JW. Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate. Science. 1982 Sep 24;217:1252. doi: 10.1126/science.7112126. [DOI] [PubMed] [Google Scholar]
  • 20.Brown JR, et al. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Dec 1;20:5995. doi: 10.1158/1078-0432.CCR-14-1622. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES